Agios Pharmaceuticals said on Friday it will stop developing its experimental drug for a type of blood cancer after a mid-stage trial failed to show enough benefit, marking…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/agios-scraps-blood-cancer-drug-program-after-study-setback-2026a1000i09?src=rss
Author :
Publish date : 2026-05-29 11:21:00
Copyright for syndicated content belongs to the linked Source.